Weekly Paclitaxel | List of Frontiers open access articles

Original Research

Published on 15 Jul 2021

Clinical and Genetic Predictive Models for the Prediction of Pathological Complete Response to Optimize the Effectiveness for Trastuzumab Based Chemotherapy

in Cancer Molecular Targets and Therapeutics

Lun Li
Min Chen
Shuyue Zheng
Hanlu Li
Weiru Chi
Bingqiu Xiu
Qi Zhang
Jianjing Hou
Jia Wang
Jiong Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.592393

4,112 views
1 citation

Study Protocol

Published on 07 Jul 2023

Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial

in Breast Cancer

Chikako Funasaka
Akiko Hanai
Sadamoto Zenda
Keita Mori
Makoto Fukui
Nami Hirano
Rie Shinohara
Nozomu Fuse
Masashi Wakabayashi
Mai Itagaki

Frontiers in Oncology

doi 10.3389/fonc.2023.1216813

5,325 views
1 citation

Clinical Trial

Published on 02 Feb 2026

Evaluation of trimetazidine in alleviating paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial

in Pharmacology of Anti-Cancer Drugs

Asmaa N. Iqbal
Fatma M. Mady
Eman Mohamed Sadek
Noha M. Abdullah
Ahmad Mostafa Abdel-Azeez
Eman Shorog
Engy A. Wahsh

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1748399

604 views

Case Report

Published on 05 Jun 2025

Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report

in Cancer Immunity and Immunotherapy

Guoning Yu
Jianqiao He
Yingna Gao
Xiaoqiong Shi
Yi Ma
Shicai Chen
Hongliang Zheng
Minhui Zhu
Caiyun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557565

3,946 views
1 citation

Original Research

Published on 20 Oct 2022

SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival

in Cancer Immunity and Immunotherapy

Ruo-Xi Wang
Peng Ji
Yue Gong
Zhi-Ming Shao
Sheng Chen

Frontiers in Immunology

doi 10.3389/fimmu.2022.940635

3,460 views
3 citations

Original Research

Published on 26 Feb 2024

NeuroPredict: study of the predictive value of ABCB1 genetic polymorphisms and associated clinical factors in chronic chemotherapy-induced peripheral neuropathy (CIPN)

in Pharmacogenetics and Pharmacogenomics

Alicia Vargas-Aliaga
María De la Haba
María José Contreras
Cristina Morales Estevez
Ignacio Porras
María Teresa Cano
Gema Pulido
María Auxiliadora Gómez
Pablo Flores-Paco
De La Haba-Rodriguez Juan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1352939

3,543 views
9 citations

Clinical Trial

Published on 10 Sep 2019

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium

in Women's Cancer

Isabelle Ray-Coquard
Ioana Braicu
Regina Berger
Sven Mahner
Jalid Sehouli
Eric Pujade-Lauraine
Philippe Alexandre Cassier
Ute Martha Moll
Hanno Ulmer
Karin Leunen

Frontiers in Oncology

doi 10.3389/fonc.2019.00832

5,403 views
27 citations

Original Research

Published on 31 Jan 2023

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO

in Breast Cancer

Serena Di Cosimo
Chiara M. Ciniselli
Sara Pizzamiglio
Vera Cappelletti
Marco Silvestri
Sarra El-Abed
Miguel Izquierdo
Mohammed Bajji
Paolo Nuciforo
Jens Huober

Frontiers in Oncology

doi 10.3389/fonc.2022.1028825

3,068 views
6 citations

Articles

Clinical and Genetic Predictive Models for the Prediction of Pathological Complete Response to Optimize the Effectiveness for Trastuzumab Based Chemotherapy

Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial

Evaluation of trimetazidine in alleviating paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial

Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report

SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival

NeuroPredict: study of the predictive value of ABCB1 genetic polymorphisms and associated clinical factors in chronic chemotherapy-induced peripheral neuropathy (CIPN)

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium

End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO